Humoral immunity after LP.8.1 monovalent vaccines against a broad range of SARS-CoV-2 variants including XEC, LP.8.1, NB.1.8.1, XFG, and BA.3.2
Yu Kaku, Mizuka Fujiwara, Keiya Uriu, Maximilian Stanley Yo, Shusuke Kawakubo, Jumpei Ito, Naoya Itoh, Yoshifumi Uwamino, Fumitake Saito, Hironori Satoh, Kei Sato
Topics & Concepts
Humoral immunityImmunityVirologyImmune systemBiologyRange (aeronautics)AntibodyChemistryImmunologyGeneticsGenetic variantsCellular immunityImmunogeneticsMonoclonal antibodySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesVaccine Coverage and Hesitancy